There are 2789 resources available
956P - A multi-analyte liquid biopsy assay integrating cfDNA methylation and protein biomarkers for liver cancer diagnosis
Presenter: Dezhen Guo
Session: ePoster Display
966P - Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy
Presenter: Alessio Cortellini
Session: ePoster Display
967P - The time of anti-PD-1 infusion improves survival outcomes by fasting conditions simulation in non-small cell lung cancer
Presenter: Anna Vilalta
Session: ePoster Display
968P - Association between use of antibiotics (ATB) and clinical outcomes with tislelizumab (tisle) monotherapy
Presenter: Zheng-Gang Ren
Session: ePoster Display
969P - Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
Presenter: Patricia Pereira
Session: ePoster Display
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display
971P - Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Presenter: Thierry Landre
Session: ePoster Display
973P - A phase II study of PDR001 among patients with recurrent and/or metastatic esophageal squamous cell carcinoma: An interim analysis of KM-12
Presenter: Dong Ki Lee
Session: ePoster Display
974P - Genetic and molecular analysis of solid tumors with hyperprogressive disease after treatment with immunotherapy
Presenter: Daniel Trotier
Session: ePoster Display
975P - Impact of body mass index on the efficacy of immune checkpoint inhibitors in cancer
Presenter: Alejandro Rios Hoyo
Session: ePoster Display